Skip to main content

Day: April 17, 2026

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced the submission of an Orphan Drug Designation (ODD) application to the U.S. Food and Drug Administration for SkinJect® (D-MNA) for the treatment of basal cell carcinoma (BCC) in patients with Gorlin Syndrome, a rare genetic disorder characterized by the development of multiple, recurrent skin cancers. The submission represents a strategic expansion of the SkinJect program into a high unmet need...

Continue reading

SAGA Metals Secures Maximum JEA Grant for Labrador and Adopts Semi-Annual Financial Reporting

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to report that it has been awarded $225,000 under the Junior Exploration Assistance (“JEA”) program, representing the maximum funding available for the 2025 program for exploration expenditures in Labrador. This funding supported the Company’s 2025 drilling program at its Radar Critical Minerals Project in Labrador. The JEA program provides non-dilutive funding to advance mineral exploration across Newfoundland and Labrador, with a focus on new discovery and development of projects toward defined mineral resources. About the Radar Critical Mineral Property in Labrador The Radar...

Continue reading

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen Training & Innovation Center (“RTIC”) at its OPUS® Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The RTIC buildout, which features product exhibits and purpose-built demonstration areas, was designed to provide customers with pre- and post-sales support, and a hands-on experience with Repligen’s innovative bioprocessing solutions. The Breda RTIC is Repligen’s third global training and innovation center, joining existing locations in Waltham, Massachusetts and Tokyo, Japan. The Breda opening event, held on April 15th, welcomed key biopharma and CDMO customers and highlighted Repligen’s...

Continue reading

Zhihu Inc. Publishes 2025 Environmental, Social and Governance Report

BEIJING, China, April 17, 2026 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that it has published its 2025 Environmental, Social and Governance (“ESG”) Report (the “Report”). The Report outlines the Company’s approach to integrating sustainability principles into its operations over the past year and highlights the Company’s continued efforts to create user value, foster a strong corporate culture, and fulfill its social responsibility, while supporting the delivery of long-term value for all stakeholders across its ecosystem. The Report is available in both Chinese and English. To support environmental conservation, shareholders and investors are encouraged to access the electronic version available on the Company’s investor relations...

Continue reading

NorthStar Earth & Space Announces Plans to Become Publicly Traded via Merger with Viking Acquisition Corp. I

Space economy has been growing rapidly (estimated $1.8T in 2035E); undetected and unmonitored space objects put national security, national sovereignty, and vitality of the space economy at risk, calling for robust infrastructure to protect high-value assets NorthStar is a highly differentiated space and satellite data analytics company established to monitor and react to active space threats, recognized as mission-critical by key defense, civil, and commercial customers Transaction includes a fully committed $30 million common stock PIPE anchored by Cartesian Capital Group, with participation from leading Canadian and U.S. institutional investors Transaction is expected to provide the business with minimum gross proceeds of $30 million, before giving effect to any additional funds remaining in the trust account New capital enables...

Continue reading

Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution

Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution17. Apr 2026 / 13:36 CET/CEST, transmitted by GlobeNewswire.The issuer is solely responsible for the content of this announcement.Notification of Major Holdings1. Details of issuerNameDeutsche Lufthansa AktiengesellschaftStreet addressVenloer Strasse 151-153Postal code50672CityCologneLEI529900PH63HYJ86ASW552. Reason for notificationAcquisition/disposal of shares with voting rightsVoluntary group notification...

Continue reading

USA Rare Earth Appoints Chaitan Kansal as Chief Commercial Officer

Seasoned Critical Minerals and Specialty Chemicals Executive to Drive Commercial Strategy Across USA Rare Earth’s Integrated Value Chain STILLWATER, Okla., April 17, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (the “Company”) today announced the appointment of Chaitan Kansal as Chief Commercial Officer. In this newly created role, Kansal will oversee the Company’s global commercial strategy, including customer engagement, market development, offtake agreements, pricing, and go-to-market execution across the Company’s integrated mine-to-magnet platform. An experienced industry leader, Kansal joins USA Rare Earth at a significant inflection point as the Company accelerates execution across its global value chain. The Company recently announced the commission of Phase 1a commercial magnet production at its Stillwater,...

Continue reading

Immuron Double Digit 3Q Sales Growth

Sales Highlights (unaudited):GlobalQ3 sales AUD$1.5 million up 16% on prior comparative period (pcp) YTD Mar 2026 sales AUD$5.7 million up 7% on prior comparative period (pcp)AustraliaQ3 sales AUD$0.9 million up 15% on prior comparative period (pcp) YTD Mar 2026 sales AUD$4.2 million up 14% on prior comparative period (pcp)CanadaQ3 sales AUD$0.1 million up >100% on prior comparative period (pcp) Q3 sales up 82% on prior quarter; initial sales to Jean Coutu, Quebec YTD Mar 2026 sales AUD$0.1 million down 65% on prior comparative period (pcp)USAQ3 sales AUD$0.5 million up 1% on prior comparative period (pcp) YTD Mar 2026 sales AUD$1.3 million up 10% on prior comparative period (pcp)MELBOURNE, Australia, April 17, 2026 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based...

Continue reading

Atour Lifestyle Holdings Limited Files 2025 Annual Report on Form 20-F

SHANGHAI, April 17, 2026 (GLOBE NEWSWIRE) — Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading lifestyle group in China, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 17, 2026. The annual report is available on the Company’s investor relations website at https://ir.yaduo.com, and on the SEC’s website at https://www.sec.gov. The Company will provide hard copies of the annual report, free of charge, to its shareholders and ADS holders upon written request. Requests should be directed to the Company’s Investor Relations Department, Atour Lifestyle Holdings Limited, 20th floor, Wuzhong Building, 618 Wuzhong Road, Minhang District, Shanghai, 200433, People’s Republic...

Continue reading

Changes in Oma Savings Bank Plc’s own shares

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 17 APRIL 2026 AT 12.50 P.M. EEST, CHANGES IN COMPANY’S OWN SHARES Changes in Oma Savings Bank Plc’s own shares  The Board of Directors of Oma Savings Bank Plc has resolved to transfer 15 785 own shares held by the company without consideration to pay the rewards for the share-based incentive plan 2024–2025 and the 2026 share instalments of the share-based incentive plans 2020–2021 and 2022–2023 to the participants of the plans in accordance with the terms and conditions of the plans. The shares will be transferred as a reward from the plan on 17.4.2026. The transfer of own shares is based on the authorisation granted by the Annual General Meeting held on 16 April 2026. After the transfer of shares, Oma Savings Bank Plc holds 133 741 own shares. Board Oma Savings Bank Plc Additional information: Karri...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.